Other antimicrobials (linezolid, quinupristin/dalfopristin)
Yamaguchi, K.; Ohno, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 2): 756-761
2003
ISSN/ISBN: 0047-1852 PMID: 12722312 Document Number: 560142
Document emailed within 1 workday
Related Documents
Miyazaki, S. 2003: Other antimicrobial agents (linezolid, quinupristin/dalfopristin, glycylcycline etc) Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 3): 241-247Schweiger, E.S.; Scheinfeld, N.S.; Tischler, H.R.; Weinberg, J.M. 2003: Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin Journal of Drugs in Dermatology: Jdd 2(4): 378-383
Johnson, A.P.; Livermore, D.M. 1999: Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal Lancet 354(9195): 2012-2013
Pérez Salmerón, J.; Martínez García, F.; Roldán Conesa, D.; Lorente Salinas, I.; López Fornás, F.; Ruiz Gómez, J.; Gómez Gómez, J.; Segovia Hernández, M.; Valdés Chávarri, M. 2006: Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 19(3): 258-266
Betriu, C.; Valverde, J.F.; Culebras, E.; Gómez, M.; Sánchez, A.; Palau, M.L.; Picazo, J.J. 1999: Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500) Enfermedades Infecciosas y Microbiologia Clinica 17(7): 335-339
Abena, P.A.; Mathieux, V.G.; Scheiff, J.M.; Michaux, L.M.; Vandercam, B.C. 2001: Linezolid and reversible myelosuppression JAMA 286(16): 1973; Author Reply 1974
Sun, C.; Chai, W.; Pan, Y.; Zhou, Y. 2014: Elution properties of linezolid bone cement Zhonghua Yi Xue Za Zhi 94(25): 1976-1978
Allcock, N.M.; Krueger, T.S.; Manley, H.J.; Kumar, V.K.; Abdallah, J. 2004: Linezolid disposition during peritonitis: a case report Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(1): 68-70
Gouin, F.ço. 2003: Contribution of linezolid to the treatment of nosocomial pneumonia Presse Medicale 32(13 Part 2): S13-S16
Roongruangpitayakul, C.; Chuchottaworn, C. 2013: Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand Journal of the Medical Association of Thailand 96(10): 1273-1282
Batts, D.H. 2000: Linezolid--a new option for treating gram-positive infections Oncology 14(8 Suppl 6: 23-29
Jankowski, A.; Stefanik, W. 2006: Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections Wiadomosci Lekarskie 59(9-10): 727-731
Shinabarger, D.L.; Marotti, K.R.; Murray, R.W.; Lin, A.H.; Melchior, E.P.; Swaney, S.M.; Dunyak, D.S.; Demyan, W.F.; Buysse, J.M. 1997: Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions Antimicrobial Agents and ChemoTherapy 41(10): 2132-2136
Coban, A.Y.; Bilgin, K.; Uzun, M.; Durupinar, B. 2009: Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates Mikrobiyoloji Bulteni 43(2): 293-297
Sköld, O. 1999: A new antibacterial agent can stop resistance development. Expectations are connected to linezolid, an oxazolidinone with a new pharmacological action Lakartidningen 96(37): 3866-3867
Totsuka, K. 2007: PK/PD of antimicrobials Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl 2(Part 1): 311-314
Sibbald, R.Gary. 2003: Topical antimicrobials Ostomy/Wound Management 49(5a Suppl): 14-18
Pérez, J.H. 2000: Pharmacoeconomics and antimicrobials Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 13(2): 159-160
Totsuka, K. 1994: Factors on antimicrobials Nihon Rinsho. Japanese Journal of Clinical Medicine 52(2): 339-343
Hutzler, R.U. 1972: Combined use of antimicrobials Revista do Hospital das Clinicas 27(6): 285-290